Suppr超能文献

药物超敏反应综合征中根据致病药物的临床表现变化。

Variation of clinical manifestations according to culprit drugs in DRESS syndrome.

机构信息

Division of Allergy, Asthma and Clinical Immunology, Department of Internal Medicine, Chonnam National University Medical School, Gwangju, Korea.

Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea.

出版信息

Pharmacoepidemiol Drug Saf. 2019 Jun;28(6):840-848. doi: 10.1002/pds.4774. Epub 2019 May 1.

Abstract

PURPOSE

Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome is a rare but serious condition that systematically damages various internal organs through T-cell-mediated immunological drug reactions. We aimed to investigate whether clinical manifestations of DRESS syndrome differ according to culprit drugs.

METHODS

We retrospectively analyzed data from 123 patients with probable/definite DRESS syndrome based on the RegiSCAR criteria (January 2011 to July 2016). The data were obtained from the Korean Severe Cutaneous Adverse Reaction Registry. Causality was assessed using the World Health Organization-Uppsala Monitoring Centre criteria. The culprit drugs were categorized as allopurinol, carbamazepine, anti-tuberculosis drug, vancomycin, cephalosporins, dapsone, and nonsteroidal anti-inflammatory drugs.

RESULTS

Differences were observed among culprit drugs regarding the frequencies of hepatitis (P < 0.01), renal dysfunction (P < 0.0001), lymphadenopathy (P < 0.01), and atypical lymphocyte (P < 0.01). Latency period differed among culprit drugs (P < 0.0001), being shorter in vancomycin and cephalosporin. In terms of clinical severity, admission duration (P < 0.01) and treatment duration (P < 0.05) differed among culprit drugs, being longer in vancomycin and anti-tuberculosis drugs, respectively.

CONCLUSIONS

Based on the findings, clinical manifestations, including latency period and clinical severity, may differ according to culprit drugs in DRESS syndrome.

摘要

目的

药物反应伴嗜酸性粒细胞增多和全身症状(DRESS)综合征是一种罕见但严重的疾病,通过 T 细胞介导的免疫药物反应系统性地损害各种内部器官。我们旨在研究 DRESS 综合征的临床表现是否因致病药物而异。

方法

我们根据 RegiSCAR 标准(2011 年 1 月至 2016 年 7 月)回顾性分析了 123 例疑似/确诊 DRESS 综合征患者的数据。这些数据来自韩国严重皮肤不良反应登记处。采用世界卫生组织-乌普萨拉监测中心标准评估因果关系。致病药物分为别嘌醇、卡马西平、抗结核药物、万古霉素、头孢菌素、氨苯砜和非甾体抗炎药。

结果

不同致病药物之间的肝炎发生率(P < 0.01)、肾功能障碍发生率(P < 0.0001)、淋巴结病发生率(P < 0.01)和非典型淋巴细胞发生率(P < 0.01)存在差异。潜伏期也因致病药物而异(P < 0.0001),万古霉素和头孢菌素较短。在临床严重程度方面,入院时间(P < 0.01)和治疗时间(P < 0.05)因致病药物而异,万古霉素和抗结核药物较长。

结论

根据研究结果,DRESS 综合征的临床表现,包括潜伏期和临床严重程度,可能因致病药物而异。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验